Patents by Inventor Mattias Magnusson
Mattias Magnusson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8273879Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: GrantFiled: March 24, 2011Date of Patent: September 25, 2012Assignee: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20110218330Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: March 24, 2011Publication date: September 8, 2011Applicant: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20110009647Abstract: The present invention is directed to a process for the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III) and to products of said process.Type: ApplicationFiled: September 17, 2010Publication date: January 13, 2011Applicant: ASTRAZENECA ABInventors: Rhony Aufdenblatten, Martin Hans Bohlin, Laurent Ducry, Ulrika Lindblad, Mattias Magnusson
-
Patent number: 7816545Abstract: The present invention is directed to a process for the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III) and to products of said process.Type: GrantFiled: November 14, 2008Date of Patent: October 19, 2010Assignee: AstraZeneca ABInventors: Rhony Aufdenblatten, Martin Hans Bohlin, Laurent Ducry, Ulrika Lindblad, Mattias Magnusson
-
Publication number: 20100004444Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: September 10, 2009Publication date: January 7, 2010Applicant: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20090182157Abstract: The present invention is directed to a process for the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III) and to products of said process.Type: ApplicationFiled: November 14, 2008Publication date: July 16, 2009Inventors: Rhony Aufdenblatten, Martin Hans Bohlin, Laurent Ducry, Ulrika Lindblad, Mattias Magnusson
-
Publication number: 20080234481Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: April 28, 2008Publication date: September 25, 2008Applicant: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Patent number: 7381828Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: GrantFiled: November 2, 2006Date of Patent: June 3, 2008Assignee: AstraZēneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20070049755Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: November 2, 2006Publication date: March 1, 2007Applicant: Astrazeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Patent number: 7067663Abstract: Pyrimidine compound (I) useful as a pharmaceutical intermediate, a process for preparing the pyrimidine compound (I), to intermediates used in the process, and use of the pyrimidine compound (I) in the preparation of pharmaceuticals. The process comprises hydrogenating a compound of formula (IV): wherein Ar is a phenyl optionally substituted by halogen, C1-4 alkyl or C1-4 alkoxy; to give a compound of formula (II): and reacting the compound of formula (II) with a salt of a compound of formula (III): to provide the compound of formula (I).Type: GrantFiled: May 31, 2001Date of Patent: June 27, 2006Assignee: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20060041132Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: October 24, 2005Publication date: February 23, 2006Applicant: AstraZeneca ABInventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Publication number: 20030148888Abstract: The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.Type: ApplicationFiled: November 7, 2002Publication date: August 7, 2003Inventors: Ulf Larsson, Mattias Magnusson, Tibor Musil, Andreas Palmgren
-
Patent number: 6487943Abstract: A torque-limiting screwdriver includes a shank disposed within a handgrip. A rear end of the shank engages the handgrip to enable an axial force to be transmitted from the handgrip to the shank. A release mechanism is provided to transmit rotation from the handgrip to the shank. The release mechanism is axially movable relative to both the handgrip and the shank and is spring biased into rotation transmitting relationship with the shank, whereby the rotation transmitting force applied to the shank is substantially independent of the axial force applied from the handgrip to the shank.Type: GrantFiled: October 10, 2000Date of Patent: December 3, 2002Assignee: Kapman ABInventors: Conny Jansson, Mattias Magnusson, Håkan Bergkvist